Upcoming Webinars

https://biopharmawebinars.com/webinars/analytical-assessment-of-leachables-in-biological-drug-products-fda-approach-in-reviewing-information-and-representative-review-cases/

Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and a Representative Review Case

Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Sarah Brophy, Global Scientific Director, E&L Element Materials Technology
24th September 2026

https://biopharmawebinars.com/webinars/aseptic-manufacturing-for-mrna-adcs-and-novel-biologics/

Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics

Presented by Francesco Cicirello, Senior Director, Global Quality Compliance – BioNTainer at BioNTech
29th September 2026

https://biopharmawebinars.com/webinars/leveraging-next-generation-sequencing-for-adventitious-agent-testing-paciras-quality-control-strategy-and-lessons-learned/

Leveraging Next-Generation Sequencing (NGS) for Adventitious Agent Testing: Pacira’s Quality Control Strategy and Lessons Learned

Presented by Po-Yi Ho, Associate Director / Analytical Development / Cell & Gene Therapies at Pacira Biosciences, and Quynh Ton, Ph.D, Regional Sales Director: NGS Application Specialist at Pathoquest
06th October 2026

https://biopharmawebinars.com/webinars/building-characterization-assays-to-support-early-stage-sarna-development-and-qc-alignment/

Building Characterization Assays to Support Early-Stage saRNA Development and QC Alignment

Presented by Yun-Ting Kao, Senior Scientist at Immunomic Therapeutics
07th October 2026

 

On Demand Webinars

https://biopharmawebinars.com/webinars/future-path-for-el-per-iso-10993-18-a-look-at-emerging-technical-specifications/

Future Path for E&L per ISO 10993‑18: A Look at Emerging Technical Specifications

Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC, Kevin Rowland, M.S, Executive Vice President and General Manager at Jordi Labs
22nd September 2026

https://biopharmawebinars.com/webinars/are-we-there-yet-a-digital-maturity-model-for-enabling-process-monitoring-and-artificial-intelligence-in-biologics-manufacturing/

Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing

Presented by Jack Prior, Head of Process Monitoring & Data/AI Strategy at Sanofi, Masaki Yamada, Head of Product at Invert
16th September 2026

https://biopharmawebinars.com/webinars/delivering-better-results-faster-at-genoway/

From Error‑Prone Manual Steps to Flexible, Automated, Audit‑Ready Workflows: Delivering Better Results, Faster at genOway 

Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout -  Director of Professional Sales (SciY)
02nd July 2026

https://biopharmawebinars.com/webinars/designed-for-more-than-launch-accelerating-biosimilar-manufacturing-at-scale/

Designed for More Than Launch: Accelerating Biosimilar Manufacturing at Scale

Presented by Mark Schofield, Cytiva, Director Science, Ingrid Long, Cytiva, Global Product Manager Bioprocess Downstream Hardware
22nd June 2026